Study: Enzyme inhibits protein linked to pulmonary hypertension

10/26/2009 | United Press International

U.S. scientists said they were able to treat pulmonary arterial hypertension in mice using an enzyme designed to block the overexpression of Notch-3, a receptor protein responsible for the disease. They believe the finding could pave the way for new treatments that would negate the need for lung transplantation in patients suffering from the condition.

View Full Article in:

United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN